{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:44:38Z","timestamp":1792817078018,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.rdc.2005.04.010","type":"journal-article","created":{"date-parts":[[2005,8,9]],"date-time":"2005-08-09T08:16:36Z","timestamp":1123575396000},"page":"451-464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Pulmonary Vascular Manifestations of Mixed Connective Tissue Disease"],"prefix":"10.1016","volume":"31","author":[{"given":"Todd M.","family":"Bull","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A.","family":"Fagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Badesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2005.04.010_bib1","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM197611182952101","article-title":"Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases","volume":"295","author":"Sharp","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2005.04.010_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM199701093360207","article-title":"Primary pulmonary hypertension","volume":"336","author":"Rubin","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2005.04.010_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1183\/09031936.03.00038903","article-title":"Inflammation in pulmonary arterial hypertension","volume":"22","author":"Dorfmuller","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rdc.2005.04.010_bib4","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1378\/chest.122.5.1668","article-title":"High prevalence of autoimmune thyroid disease in pulmonary arterial hypertension","volume":"122","author":"Chu","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.rdc.2005.04.010_bib5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1164\/ajrccm.155.1.9001324","article-title":"Primary pulmonary hypertension, tissue plasminogen activator antibodies, and HLA-DQ7","volume":"155","author":"Morse","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rdc.2005.04.010_bib6","first-page":"75","article-title":"Immunological studies in \u2018primary\u2019 idiopathic pulmonary hypertension","volume":"7","author":"Asherson","year":"1984","journal-title":"Eur J Rheumatol Inflamm"},{"issue":"Suppl","key":"10.1016\/j.rdc.2005.04.010_bib7","doi-asserted-by":"crossref","first-page":"231S","DOI":"10.1378\/chest.114.3_Supplement.231S","article-title":"Genetics and immunogenetic aspects of primary pulmonary hypertension","volume":"114","author":"Barst","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.rdc.2005.04.010_bib8","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/0002-9343(78)90455-2","article-title":"Pulmonary vascular changes in scleroderma","volume":"64","author":"Young","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2005.04.010_bib9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0046-8177(97)90032-0","article-title":"Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection","volume":"28","author":"Cool","year":"1997","journal-title":"Hum Pathol"},{"key":"10.1016\/j.rdc.2005.04.010_bib10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0049-0172(84)90015-5","article-title":"Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus","volume":"13","author":"Quismorio","year":"1984","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2005.04.010_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/ard.34.5.457","article-title":"Lupus cor pulmonale with electron microscope and immunofluorescent antibody studies","volume":"34","author":"Yeo","year":"1975","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2005.04.010_bib12","first-page":"416","article-title":"Pulmonary hypertension in systemic lupus erythematosus: a report of three cases","volume":"13","author":"Asherson","year":"1986","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2005.04.010_bib13","first-page":"1","article-title":"Pulmonary hypertension and systemic lupus erythematosus","volume":"13","author":"Asherson","year":"1986","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2005.04.010_bib14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/art.1780290409","article-title":"Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis","volume":"29","author":"Stupi","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2005.04.010_bib15","first-page":"1923","article-title":"Pulmonary hypertension in systemic lupus erythematosus: clinical association and survival in 18 patients","volume":"26","author":"Li","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2005.04.010_bib16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0002-9343(84)90783-6","article-title":"Raynaud's phenomenon of the lung","volume":"76","author":"Fahey","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2005.04.010_bib17","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/art.1780260815","article-title":"Vascular reactivity and pulmonary hypertension in systemic sclerosis","volume":"26","author":"Rozkovec","year":"1983","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2005.04.010_bib18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00007611-200106000-00018","article-title":"Pulmonary hypertension associated with HIV infection","volume":"94","author":"Seoane","year":"2001","journal-title":"South Med J"},{"key":"10.1016\/j.rdc.2005.04.010_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/000331970105200105","article-title":"Primary pulmonary hypertension in HIV patients: a systematic review","volume":"52","author":"Pellicelli","year":"2001","journal-title":"Angiology"},{"key":"10.1016\/j.rdc.2005.04.010_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1183\/09031936.03.00006903","article-title":"Primary pulmonary hypertension, Castleman's disease and human herpesvirus-8","volume":"22","author":"Bull","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rdc.2005.04.010_bib21","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa035115","article-title":"Expression of human herpesvirus 8 in primary pulmonary hypertension","volume":"349","author":"Cool","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2005.04.010_bib22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/303059","article-title":"Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene","volume":"67","author":"Deng","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.rdc.2005.04.010_bib23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1086\/316947","article-title":"BMPR2 Haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension","volume":"68","author":"Machado","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.rdc.2005.04.010_bib24","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/jmg.37.10.741","article-title":"Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family","volume":"37","author":"Thomson","year":"2000","journal-title":"J Med Genet"},{"key":"10.1016\/j.rdc.2005.04.010_bib25","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/art.10487","article-title":"Mutations of bone morphogenetic protein receptor type II are not found in patients with pulmonary hypertension and underlying connective tissue diseases","volume":"46","author":"Tew","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2005.04.010_bib26","first-page":"2379","article-title":"Pulmonary hypertension in scleroderma spectrum of disease: lack of bone morphogenetic protein receptor 2 mutations","volume":"29","author":"Morse","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2005.04.010_bib27","first-page":"S105","article-title":"Pulmonary hypertension in patients with connective tissue disease and antibody to nuclear ribonucleoprotein","volume":"24","author":"Esther","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2005.04.010_bib28","first-page":"499","article-title":"Severe pulmonary involvement in mixed connective tissue disease","volume":"124","author":"Wiener-Kronish","year":"1981","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.rdc.2005.04.010_bib29","first-page":"826","article-title":"Mixed connective tissue disease with pulmonary hypertension: a clinical and pathological study","volume":"14","author":"Hosoda","year":"1987","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2005.04.010_bib30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2005.04.010_bib31","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.CIR.70.4.580","article-title":"Primary pulmonary hypertension: natural history and the importance of thrombosis","volume":"70","author":"Fuster","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2005.04.010_bib32","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/0002-9149(91)90330-N","article-title":"Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease","volume":"68","author":"Alpert","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.rdc.2005.04.010_bib33","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1378\/chest.98.3.759","article-title":"Nifedipine and prazosin in the management of pulmonary hypertension in CREST syndrome","volume":"98","author":"Glikson","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.rdc.2005.04.010_bib34","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0002-8703(85)90618-0","article-title":"Sustained benefit of verapamil in pulmonary hypertension with progressive systemic sclerosis","volume":"109","author":"O'Brien","year":"1985","journal-title":"Am Heart J"},{"key":"10.1016\/j.rdc.2005.04.010_bib35","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0002-9343(05)80003-8","article-title":"Cardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captopril","volume":"90","author":"Sfikakis","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2005.04.010_bib36","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1378\/chest.102.5.1407","article-title":"Short- and long-term hemodynamic effects of captopril in patients with pulmonary hypertension and selected connective tissue disease","volume":"102","author":"Alpert","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.rdc.2005.04.010_bib37","first-page":"59","article-title":"Prostacyclin: its biosynthesis, actions, and clinical potential","volume":"10","author":"Dusting","year":"1982","journal-title":"Adv Prostaglandin Thromboxane Leukot Res"},{"issue":"Suppl","key":"10.1016\/j.rdc.2005.04.010_bib38","doi-asserted-by":"crossref","first-page":"99S","DOI":"10.1378\/chest.114.1_Supplement.99S","article-title":"Pulmonary prostacyclin synthase overexpression by adenovirus transfection and in transgenic mice","volume":"114","author":"Geraci","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.rdc.2005.04.010_bib39","doi-asserted-by":"crossref","first-page":"11660","DOI":"10.1074\/jbc.274.17.11660","article-title":"Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2","volume":"274","author":"Brock","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rdc.2005.04.010_bib40","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1164\/ajrccm\/140.6.1623","article-title":"The acute administration of vasodilators in primary pulmonary hypertension: experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension","volume":"140","author":"Weir","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.rdc.2005.04.010_bib41","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-112-7-485","article-title":"Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol): results of a randomized trial","volume":"112","author":"Rubin","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2005.04.010_bib42","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: a randomized, controlled trial","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2005.04.010_bib43","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2005.04.010_bib44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0952-3278(93)90105-6","article-title":"The pharmacokinetics and pharmacodynamics of the prostacyclin analog 15AU81 in the anesthetized beagle dog","volume":"48","author":"McNulty","year":"1993","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.rdc.2005.04.010_bib45","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double- blind, randomized, placebo-controlled trial","volume":"165","author":"Simonneau","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rdc.2005.04.010_bib46","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1378\/chest.126.2.420","article-title":"Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease","volume":"126","author":"Oudiz","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.rdc.2005.04.010_bib47","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2005.04.010_bib48","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2005.04.010_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/107424840200700i102","article-title":"Endothelin in health and disease: endothelin receptor antagonists in the management of pulmonary artery hypertension","volume":"7","author":"Kim","year":"2002","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.rdc.2005.04.010_bib50","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1378\/chest.124.1.247","article-title":"Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study","volume":"124","author":"Sitbon","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.rdc.2005.04.010_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1054-3589(08)60047-2","article-title":"Cyclic GMP: synthesis, metabolism, and function. Introduction and some historical comments","volume":"26","author":"Murad","year":"1994","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.rdc.2005.04.010_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(00)00824-4","article-title":"Phosphodiesterase 5 inhibitors and nitrergic transmission-from zaprinast to sildenafil","volume":"411","author":"Gibson","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.rdc.2005.04.010_bib53","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1161\/01.CIR.0000016641.12984.DC","article-title":"Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide","volume":"105","author":"Michelakis","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2005.04.010_bib54","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1136\/heart.84.2.e4","article-title":"Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension","volume":"84","author":"Abrams","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.rdc.2005.04.010_bib55","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM200011023431814","article-title":"Sildenafil in primary pulmonary hypertension","volume":"343","author":"Prasad","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2005.04.010_bib56","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1378\/chest.123.4.1293","article-title":"Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension","volume":"123","author":"Stiebellehner","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.rdc.2005.04.010_bib57","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/ard.55.8.561","article-title":"Improvement of severe pulmonary hypertension in a patient with SLE","volume":"55","author":"Karmochkine","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2005.04.010_bib58","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/096120339300200606","article-title":"Pulmonary arterial hypertension responsive to immunosuppressive therapy in systemic lupus erythematosus","volume":"2","author":"Morelli","year":"1993","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2005.04.010_bib59","first-page":"1055","article-title":"Primary pulmonary hypertension in a patient with systemic lupus erythematosus: partial improvement with cyclophosphamide","volume":"20","author":"Groen","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2005.04.010_bib60","first-page":"1976","article-title":"Precapillary pulmonary hypertension dramatically improved with high doses of corticosteroids during systemic lupus erythematosus","volume":"21","author":"Goupille","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2005.04.010_bib61","first-page":"1807","article-title":"Ten year survival of a patient with advanced pulmonary hypertension and mixed connective tissue disease treated with immunosuppressive therapy","volume":"19","author":"Dahl","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2005.04.010_bib62","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0272-5231(05)70113-1","article-title":"Respiratory complications in mixed connective tissue disease","volume":"19","author":"Prakash","year":"1998","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.rdc.2005.04.010_bib63","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0025-6196(12)64786-7","article-title":"Intrathoracic manifestations in mixed connective tissue disease","volume":"60","author":"Prakash","year":"1985","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.rdc.2005.04.010_bib64","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00005792-198403000-00003","article-title":"A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease","volume":"63","author":"Sullivan","year":"1984","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2005.04.010_bib65","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00005382-200104000-00005","article-title":"Pulmonary involvement in mixed connective tissue disease: high-resolution CT findings in 41 patients","volume":"16","author":"Kozuka","year":"2001","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.rdc.2005.04.010_bib66","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000194818","article-title":"Bilateral exudative pleuritis, an unusual pulmonary onset of mixed connective tissue disease","volume":"48","author":"Hoogsteden","year":"1985","journal-title":"Respiration (Herrlisheim)"},{"key":"10.1016\/j.rdc.2005.04.010_bib67","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00005792-199705000-00005","article-title":"Diffuse alveolar hemorrhage and systemic lupus erythematosus: clinical presentation, histology, survival, and outcome","volume":"76","author":"Zamora","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2005.04.010_bib68","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0272-6386(84)80004-9","article-title":"Pulmonary hemorrhage and acute renal failure in a patient with mixed connective tissue disease","volume":"3","author":"Germain","year":"1984","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.rdc.2005.04.010_bib69","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1378\/chest.113.6.1609","article-title":"Isolated pulmonary capillaritis and diffuse alveolar hemorrhage in rheumatoid arthritis and mixed connective tissue disease","volume":"113","author":"Schwarz","year":"1998","journal-title":"Chest"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X05000232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X05000232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:56:51Z","timestamp":1760180211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X05000232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0889857X05000232"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2005.04.010","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary Vascular Manifestations of Mixed Connective Tissue Disease","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2005.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}